Since changes in SYNGAP1 have previously been linked to intellectual disabilities and other neurodevelopmental disorders in humans [21], the present study raises the possibility that SYNGAP1 may prove to be a key molecular mediator of the association between cannabis use in adolescence and adverse neuropsychiatric outcomes in adulthood [22]. The gene discussed is SYNGAP1; the disease is Intellectual disability.